Jupiter Asset Management LTD Coherus Bio Sciences, Inc. Transaction History

Jupiter Asset Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$5.86 - $13.23 $158,243 - $357,262	27,004 New	27,004 $196,000
Q4 2021 Feb 11, 2022	SELL	$15.81 - $18.99 $2.17 Million - $2.61 Million	-137,344 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$12.68 - $17.79 $4.01 Million - $5.62 Million	-315,868 Reduced 69.7%	137,344 $2.21 Million
Q2 2021 Aug 10, 2021	BUY	$12.95 - $15.41 $2.37 Million - $2.82 Million	183,212 Added 67.86%	453,212 $6.27 Million
Q1 2021 May 12, 2021	BUY	$14.42 - $21.39 $1.01 Million - $1.5 Million	70,000 Added 35.0%	270,000 $3.95 Million

Q3 2020 Nov 10, 2020	BUY	$17.41 - $19.89 $3.48 Million - $3.98 Million	200,000 New	200,000 $3.66 Million

148

82.9M

184K

255K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $108M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Jupiter Asset Management LTD with notifications on news.